Lifesaving service launched to support people with diabetes after heart attacks
Professor Kelvin Lee, Consultant Interventional Cardiologist and Director of the Cardiovascular Research Programme at ULHT, said: “Before launching the new service, we knew that many patients with acute coronary syndrome (ACS) with existing or newly diagnosed diabetes were not always being followed up in the separate cardiology or diabetes clinic, or by their GPs in primary care in a timely manner, nor had their cardiovascular-diabetic treatment subsequently optimised after being discharged.”
“Our partnership with Boehringer Ingelheim has allowed us to use our existing staff, and has included a focus on educating and training our cardiac advanced clinical practitioners (ACPs), and adapting our current processes to provide a better service for our patients for a more joined up approach to their care.”
“Diabetes can be quite a daunting diagnosis for many patients, and for those who then also go on to have a heart attack or acute coronary syndrome. The easier we can make it to help our patients manage their conditions the better to help prevent future emergency situations such as heart attack, heart failure or cardiac arrest.”
The new pathway can also help to alleviate pressure on primary care networks by providing joined up care in an acute setting, before handing over care to GP services.
Dr Carl Deaney, GP at Marsh Medical Practice who leads long term condition projects in his Primary Care Network, said: “Patients with ACS and diabetes often require GP appointments in addition to outpatient appointments following an acute event (such as a heart attack) to help manage their conditions and the associated symptoms.”
“Complimentary treatments that are optimised for both ACS and diabetes can help reduce the need for GP appointments, and better education for patients to help them manage, both of the conditions, simultaneously rather than separately which may inadvertently cause other issues.
“As the service expands, further knowledge of the new clinic within primary care can help us to work closely with our colleagues in the Lincoln Heart Centre for better patient care.”
Dr Christoph Zehendner, Medical Director at Boehringer Ingelheim said: “We are proud to support the NHS as it continues to design, deliver and evaluate innovative models of care to improve patient outcomes and respond to the secondary prevention challenge.
“We share the goal of this dedicated team at Lincolnshire NHS Trust to ensure patients receive holistic personalised care. This partnership project is one of many that Boehringer Ingelheim is supporting to identify innovative models of care to ensure a sustainable future for the NHS.”
Since its inception in 2021, the cardio-diabetes service has now seen more than 280 patients with diabetes following their heart attack or ACS, ensuring improved and optimised cardio-diabetes care. The service is being commissioned by ULHT to continue to provide this novel approach in healthcare for patients in Lincolnshire.
I would like to make a regular donation of
I would like to make a single donation of